Enveric Biosciences, Inc.
corporate_fare Company Profile
Enveric Biosciences, Inc. (NASDAQ:ENVB) is a publicly traded company in the Life Sciences sector. Wiseek monitors ENVB SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Enveric Biosciences Finalizes $1.5M Registered Direct Offering at Premium to Market Price
- Enveric Biosciences Secures $1.25M in Dilutive Offering with Warrants Amidst Ongoing Capital Needs
- Enveric Biosciences Outlines Q1 2026 Clinical Development Path for Lead Neuroplastogen EB-003
- Enveric Biosciences Secures $3.1M Capital Infusion, Registers 882K Shares for Resale
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$8.77M
Diluted EPS
-$36.24
Op. Cash Flow
-$8.14M
Operating Income
-$8.77M
Cash & Equivalents
$4.68M
Debt / Equity
0.00×
Shares Outstanding
1.06M sh
Source: 10-K · filed 2026-03-27 · accession 0001493152-26-013294
show_chartPrice Chart
Loading chart...
feed ENVB - Filings & News (Page 2)
ENVB
Jan 28, 2026, 5:00 PM EST
Price at Filing:
$3.45
Real-time Price:
$1.70
Change:
-$1.75 (-51%)
Market Cap:
$5.633M
ENVB
Jan 28, 2026, 1:33 PM EST
Price at Filing:
$3.46
Real-time Price:
$1.70
Change:
-$1.76 (-51%)
Market Cap:
$5.633M
ENVB
Jan 09, 2026, 5:23 PM EST
Price at Filing:
$4.02
Real-time Price:
$1.70
Change:
-$2.32 (-58%)
Market Cap:
$5.633M
ENVB
Jan 02, 2026, 8:26 AM EST
Price at Filing:
$3.55
Real-time Price:
$1.70
Change:
-$1.85 (-52%)
Market Cap:
$5.633M